| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | -100.0% | -100.0% |
| Cost of Revenue | $0 | — | -100.0% |
| Gross Profit | $0 | — | -100.0% |
| R&D Expense | $4K | -42.9% | -75.0% |
| SG&A Expense | $470K | +91.8% | +35.8% |
| Operating Income | -$474K | -90.4% | -58.5% |
| Interest Expense | $2K | -77.8% | +0.0% |
| Net Income | -$476K | -84.5% | -182.2% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $31K | +3.3% | -95.4% |
| Accounts Receivable | $0 | -100.0% | — |
| Current Assets | $44K | -10.2% | -93.7% |
| Total Assets | $55K | -8.3% | -92.3% |
| Current Liabilities | $153K | +54.5% | -75.0% |
| Long-term Debt | $150K | +0.0% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$401K | -83.1% | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $183K | — | — |
| +17.2% |
| Total Liabilities | $303K | +21.7% | -59.1% |
| Stockholders' Equity | -$248K | -31.2% | -978.3% |